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Microbial biofilms have become increasingly problematic in the food processing and medical industries where they cause food and surface
contamination. Biofilms have also been implicated as the cause of serious infections in humans as their occurrence makes it difficult to treat
common infections and the likelihood of recurrent infections is high. Due to emerging resistance, conventional control methods are fast becoming
ineffective. In this study, the use of a selection of commercial plant extracts is investigated. The inhibitory effects of eight herbal extracts on the
development of microbial biofilms was investigated against clinical and reference strains of Pseudomonas aeruginosa and Candida albicans. The
antimicrobial activity was investigated on the planktonic forms using the minimum inhibitory concentration assay. The extracts that showed the
highest antimicrobial activity against the two test organisms were Echinacea angustifolia (cone flower), Mentha piperita (peppermint) and
Rosmarinus officinalis (rosemary) with minimum inhibitory concentration values between 0.38 and 2.5 mg/ml. The crystal violet assay was used
to assess the effect of pre-treating a surface with plant extracts on cell attachment and the extent of biofilm development following exposure to
extracts (biofilm biomass). Most of the extracts reduced microbial colonization by at least 50%. In contrast, preformed biofilms were less
responsive to the majority of extracts, thus growth inhibition was more difficult to achieve.Mentha piperita was the only extract that showed some
antibiofilm activity against both pathogens.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Antiadhesion; Biofilm; Commercial herbs; P. aeruginosa; C. albicans1. Introduction
The formation of micro-organisms in layers and their
metabolic and decomposition products on various surfaces
results in the formation of biofilms (Kumar and Anand, 1998).
Advantages associated with biofilm formation include protec-
tion from the environment, nutrient availability, metabolic
cooperation and acquisition of new genetic material (Jabra-Rizk
et al., 2004). The most common problematic biofilms which
occur on almost every individual is plaque that harbours oral
bacteria on teeth and causes tooth decay (Bauman, 2006).
Biofilms have also been implicated as the cause of serious
infections although infections are not exclusively a result of
biofilm formation (Spoering and Lewis, 2001). In addition,
contamination of indwelling medical devices such as artificial⁎ Corresponding author. Tel.: +27 12 3826360; fax: +27 12 3826342.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2010.05.011joints, prosthetic heart valves, catheters and dentures has also
resulted in some serious infections (Hugo and Russell, 2004).
The methods that are currently used for the control of
biofilms include physical, chemical and more recently biolog-
ical methods (Kumar and Anand, 1998; Steinberg et al., 2005).
Physical methods commonly used include heat and mechanical
scrubbing, brushing, scraping and high pressure spraying
(Dreeszen, 2003). The use of chemical biocides such as
disinfectants, detergents and preservatives is also common
(Kumar and Anand, 1998). Bacteriocins and enzymes are also
used on a smaller scale as biocontrol agents in the food industry,
however, limitations include availability and cost (Kumar and
Anand, 1998). Although a number of control measures are in
place for biofilm control, most of these seem to be almost
ineffective due to the increased resistance conferred by sessile
cells. In an effort to identify alternative biofilm control methods,
plants have been identified as potential candidates as many
herbal extracts have shown to exhibit antimicrobial properties.ts reserved.
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almost exclusively focused on the planktonic micro-organisms
while the sessile forms that are more resistant to antimicrobial
agents and therefore more difficult to control, remain largely
unexplored. This paper reports the antimicrobial activity of
planktonic forms, antibiofilm adhesion potential and the prevention
of further growth of established biofilms of eight plant extracts
using two micro-organisms, Candida albicans and Pseudomonas
aeruginosa.2. Materials and methods
2.1. Selection and preparation of plant material
Eight herbs of commercial importance were purchased from
Warren Chem Specialties, Herbs-A-Plenty and Unilever South
Africa. These were selected on the basis of their commercial
importance as most of them are consumed due to their health
benefits. The herbs used and their commercial importance are
presented in Table 1. The fresh herbs were initially air-dried at
room temperature and ground to a fine powder in a blender.
Dichloromethane/methanol (CH2CI2/MeOH, 1:1) extracts of
the powdered herbs were prepared using a method adapted from
Sandasi et al. (2008).2.2. Minimum inhibitory concentrations
To confirm the antimicrobial activity of the selected herbs, the
extracts were initially tested on planktonic micro-organisms using
the modified p-iodonitrotetrazolium violet (INT) microplate,
minimum inhibitory concentration (MIC) assay (Eloff, 1998).
Both clinical and laboratory strains of P. aeruginosa and C.
albicans were used in this assay. C. albicans clinical strain CI002
was supplied by the microbiology laboratory, Department of
Pharmaceutical Sciences, Faculty of Science, Tshwane University
of Technology. P. aeruginosa (clinical strain FRD1) was supplied
byResearch andDevelopment, Onderstepoort Biological Products.
Reference strains P. aeruginosa (ATCC 9027) and C. albicans
(ATCC 10231) were obtained from the microbiology laboratory,
Department of Pharmacy and Pharmacology, Faculty of Health
Sciences, University of Witwatersrand. The organisms wereTable 1
Minimum inhibitory concentrations (mg/ml) of eight herbal extracts against two pat
Plant Commercial
application
P.
AT
Echinacea angustifolia (Echinacea/cone flower ) Medicinal herb 0.7
Mentha piperita (Peppermint) Spicing agent 0.7
Rosmarinus officinalis (Rosemary) Spicing agent 1.5
Melaleuca alternifolia (Tea tree) Medicinal herb 2.0
Hypericum perforatum (St John's Wort ) Herbal tea 3.0
Thymus vulgaris (Thyme) Spicing agent 1.0
Aspalathus linearis (Rooibos) Herbal tea 4.0
Camelia sinensis (Green tea) Herbal tea 8.0
Controls a 0.0
a Ciprofloxacin and amphotericin B were used as controls against P. aeruginosaselected on the basis of their pathogenicity and their ability to
form biofilms.
The extracts were dissolved in sterile water and tested using
the same range of concentrations (0.0625–8 mg/ml). The
positive control for P. aeruginosa was ciprofloxacin and
amphotericin B was used for the C. albicans strains. The
negative control was water. The MIC procedure was carried out
by aliquoting one hundred microlitres (100 μl) of sterile
distilled water into all the wells of the microtitre plate. The
prepared extracts were then pipetted into the first well in each
column in triplicate. Serial dilutions were performed in
decreasing concentrations down the columns. Following the
serial dilutions, 100 μl of the standard culture (1.0×106 CFU/ml)
was added to all the wells. The plates were sealed with sterile
adhesive tape and incubated at 37 °C for 24 h for P. aeruginosa
and 48 h for C. albicans. Following incubation, the MIC assay
was determined. To visualise the bacterial growth, 40 μl of INT
(0.04 mg/ml) was added to each well and the plates incubated at
room temperature for 6 h. For the yeasts, plates were incubated at
room temperature for 24 h. The plates were then examined for
colour changes and the MIC was indicated by the first clear well
(lowest concentration having no microbial growth) in a column.2.3. Inhibition of biofilm formation
To prevent initial cell attachment, 100 μl of plant extracts were
aliquoted into wells of a 96 well microtitre plate. Standardised
cultures (1.0×106 CFU/ml) of P. aeruginosa andC. albicanswere
then added (100 μl) into the wells and incubated for 4 h at 37 °C
without shaking (Sandasi et al., 2008). The final concentration of
the extracts in the wells was 1 mg/ml while ciprofloxacin at a
concentration of 0.0025 mg/ml (MIC value) and amphotericin B at
0.0050 mg/ml (MIC value) were used as the positive controls forP.
aeruginosa and C. albicans, respectively. Water was used as the
negative control. Following incubation, the biofilm biomass was
assayed using the modified crystal violet (CV) staining assay and
percentage inhibition determined using Eq. 1 (Djordjevic et al.,
2002).
Percentage inhibition =
ODNegative control−ODExperimental × 100
ODNegative control
ð1Þhogens.
aeruginosa P. aeruginosa C. albicans C. albicans
CC 9027 Clinical FRD1 ATCC 10231 Clinical CI002
5 1.00 1.00 0.38
5 1.00 2.50 1.00
0 1.00 1.00 0.75
0 2.00 1.50 2.00
0 1.00 3.00 1.00
0 8.00 1.25 1.00
0 8.00 3.00 1.00
0 2.00 2.00 1.50
025 0.0025 0.005 0.005
and C. albicans, respectively.
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To test the ability of the extracts to prevent biofilm
development, biofilms were pre-formed in 96 well microtitre
plates by aliquoting 100 μl of standardized P. aeruginosa and
C. albicans (1.0×106 CFU/ml) into the wells and incubated
for 4 h at 37 °C. Following incubation, 100 μl of each of the
plant extract that showed some degree of inhibiting cell
attachment (six extracts) was added to a final concentration
of 1.00 mg/ml in the wells. Ciprofloxacin at a concentration
of 0.0025 mg/ml (MIC value) and amphotericin B at
0.0050 mg/ml (MIC value) were used as the positive controls
for P. aeruginosa and C. albicans, respectively. Water was
used as the negative control. The plates were further
incubated for 24 h at 37 °C (Sandasi et al., 2008). Following
incubation with the extracts, the crystal violet assay was
performed to assay for biofilm biomass.2.5. Crystal violet staining assay
The plates were washed three times with distilled water
following incubation, then oven-dried at 60 °C for 45 min.
Following drying, the wells were stained with 100 μl of 1%
crystal violet and incubated at room temperature for 15 min
after which the plates were washed three times with sterile
distilled water to remove unadsorbed stain. The semi-quantita-
tive assessment of biofilm formation was performed by adding
125 μl of ethanol to destain the wells. One hundred microlitres
(100 μl) of the destaining solution was then transferred to a new
plate and the absorbance determined at 590 nm using a
microplate reader (Universal microplate reader ELX 800). The
mean absorbance (OD590 nm) of the samples was determined and
percentage inhibition obtained using Eq.1.Fig. 1. The effect of herbal extracts on P. aeruginosa ATCC 9027 (▀) and clinical FR
inhibited biofilm formation have positive values while extracts that enhanced forma3. Results and discussion
3.1. Minimum inhibitory concentrations
Generally, most extracts used had MIC values in the order of
1.00–3.00 mg/ml against both pathogens (Table 1). Noteworthy
activity (MIC 0.38–1.00 mg/ml) was observed for E. angusti-
folia against all the isolates. This was followed to a lesser extent
by M. piperita (0.75–2.50 mg/ml) and R. officinalis (0.75–
1.50 mg/ml). For C. albicans, the clinical strain showed higher
susceptibilities for all plant extracts with the exception of M.
alternifolia. For P. aeruginosa, the clinical and ATCC strains
exhibited variable susceptibility which was extract dependant.
The results confirm the antimicrobial activity of these
extracts as previously reported (Cowan, 1999; Kuete et al.,
2008; Landete et al., 2008; Taylor et al., 1996). Research has
shown that various spices exhibit antimicrobial activity against
a wide range of micro-organisms; however the efficacy differs
depending on the choice of plant material, solvent used for
extraction, composition and concentration of secondary meta-
bolites, and choice of test organisms. Phenolic compounds are
believed to significantly contribute to the overall antimicrobial
activity of extracts (Kim et al., 2002; Shan et al., 2007). The
good activity observed thus warranted further investigation for
antibiofilm activity.3.2. Prevention of cell attachment
Six of the eight extracts showed some degree of antiadhesion
activity however, only 3 extracts showed good activity against the
ATCC isolate with a percentage inhibitionN50% (Fig. 1). These
were E. angustifolia (62%),M. piperita (57%), and R. officinalis
(56%) with activities comparable to ciprofloxacin (60%). None ofD1 (□) biofilm formation expressed as percentage inhibition. (The extracts that
tion show negative inhibition).
Fig. 2. The effect of herbal extracts on C. albicans ATCC 10231 (▀) and clinical CI002 (□) biofilm formation expressed as percentage inhibition.
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evidenced by the low percentage inhibition values of less than
50% (Fig. 1). This shows that the ATCC isolate was more
susceptible to the extracts than the clinical isolate. Fig. 1 also
shows 2 extracts (C. sinensis and H. perforatum) that enhanced
cell attachment (negative percentage inhibition) for both the
ATCC and clinical isolates. The presence of the extracts seemed
to enhance biofilm formation of P. aeruginosa.
Fig. 2 shows that most extracts had minimal or no inhibitory
effect on the attachment of C. albicans. Instead most extracts
promoted cell attachment. E. angustifolia and R. officinalis had
an inhibitory effect against both ATCC and clinical isolates;
however none of these was effective enough to give a 50%
reduction in cell attachment (Fig. 2). It is noteworthy that the
same extracts also gave significant anti-adhesion activities
against P. aeruginosa thus the two are promising candidates for
further investigation as anti-adhesion agents.Fig. 3. The effect of herbal extracts on P. aeruginosa ATCC 9027 (▀) and cl3.3. Prevention of biofilm development
The two extracts (C. sinensis and H. perforatum) that did not
show anti-adhesion properties were not further assessed for
biofilm development, thus only six extracts were evaluated
further. Fig. 3 shows that most of the extracts were unable to
inhibit the growth and development of a pre-formed biofilm.
Instead, enhanced growth and development of the biofilm was
observed for most of the extracts against both isolates. Only M.
piperita showed antibiofilm development (38% inhibition).
The results for C. albicans (Fig. 4) showed a similar trend to
that of P. aeruginosa. Minimal activity was exhibited by only A.
linearis (8%) and M. piperita (28%) extracts against both
isolates. The majority of the extracts enhanced the development
of the biofilm with T. vulgaris and M. alternifolia showing at
least a two-fold increase against both isolates. These results
indicate that the extracts either had minimal or no antibiofilminical FDR1 (□) biofilm development expressed as percentage inhibition.
Fig. 4. The effect of herbal extracts on C. albicans ATCC 10231 (▀) and clinical CI002 (□) biofilm development expressed as percentage inhibition.
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extract that exhibited antibiofilm activity against both patho-
gens although in both cases activity was less than 50%. The
enhanced biofilm development observed for T. vulgaris, R.
officinalis, M. alternifolia and E. angustifolia is consistent with
both pathogens studied. These results show that inhibition of
preformed biofilm development proved to be more difficult to
achieve than cell attachment.
The absence of antibiofilm activity for most of the plant
extracts is evidence that cells in a biofilm are more resistant to
antimicrobial agents compared to free-floating or planktonic
cells (Frank and Koffi, 1990; Krysinski et al., 1992). The ease
with which the plant extracts inhibited cell attachment is
confirmation of previous reports where it was found that
inhibition of cell attachment to a substrate is easier to achieve
than inhibiting the growth of an already established biofilm
(Cerca et al., 2005). The success of selected plant extracts in
inhibiting cell attachment as shown in this study is a promising
tool for reducing microbial colonisation of surfaces and
epithelial mucosa which subsequently leads to infections.
Regular consumption of selected commercially popular herbs
may thus play a role in the prevention of biofilms. Some
researchers have demonstrated the success of coating medical
devices with biocides such as silver to reduce microbial
adhesion and the subsequent disease pathogenesis has been
demonstrated (Hashimoto, 2001; Klueh et al., 2000). Milk
constituents and chitosan are other non-herbal natural products
that have been reported to inhibit cell attachment (Cai et al.,
1994; Sharon and Ofek, 2001).
Literature on the antibiofilm activity of plant extracts is
currently minimal. The results obtained for M. piperita warrant
further investigation as a promising candidate for antibiofilm
activity and to validate its activity. Previous reports have shown
that M. piperita exhibits good antibiofilm activity against the
Gram-positive pathogen, L. monocytogenes (Sandasi et al.,
2008). Bupesh et al. (2007) showed that organic leaf extracts of
M. piperita possess broad spectrum antibacterial activity against
a wide range of bacteria. This activity has been attributed to thepresence of potent compounds that include menthol, menthone,
menthyl acetate and menthofuran. Menthol on its own has been
shown to be inhibitory against bacteria, fungi and viruses,
which contribute to the overall antimicrobial activity of the M.
piperita extract (Bupesh et al., 2007).
The enhanced biofilm development observed for some
extracts in this study is not fully understood. Literature however
reports that the presence of some substances plays an important
role in promoting microbial adhesion. Mention has been made
of albumin, gelatin, fibrinogen and casein for promoting
microbial adhesions (Meadows, 1971). The enhancement of
cell attachment observed for some extracts in this study may be
due to the presence of certain compounds within the extracts
that also promote microbial adhesion. Further investigations on
the mechanisms involved in this growth enhancement need to
be undertaken to better understand the behaviour of cells in a
biofilm.
The results also indicate that good antimicrobial activity
against planktonic micro-organisms does not imply good
antibiofilm activity. This was observed where most extracts
that showed good MIC values had minimal or no antibiofilm
activity against the same pathogens. It is therefore imperative to
carry out investigations on both sessile and planktonic cells to
ensure that extracts that provide a broader inhibitory activity are
identified.
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